FormDSignal
50

Phoenix Life Sciences Feb 2026 closes $24K private equity fund in Delaware

New fund · Private equity / buyout · Closed · CLAYMONT, DE · Form D filed 2026-10-05 · sponsor: CGF

Phoenix Life Sciences Feb 2026, a series of CGF2021 LLC, is a newly formed Delaware private equity fund that closed a $24K offering on October 1, 2026. The fund has admitted 2 investors and is structured under Regulation D exemptions 3(c)(1) and 3(c)(7).

Note: Micro-sized offering ($24K) with minimal investor count (2); verify this is not a test filing or placeholder entity.

First filing by this entityPrivate equity / buyout

Why now — by persona

  • Fund administrator:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
  • Fund audit & tax:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock

People on the filing

LLC SydecarAdministrator of the Issuer
Brett SaganOfficer of the Issuer's Administrator

Signed by Brett Sagan, General Manager of Sydecar LLC, a Manager of the Applicant.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.

More from CGF